Related Experiment Video
Updated: Jul 5, 2025

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
Rapid turnover of CTLA4 is associated with a complex architecture of reversible ubiquitylation
Pei Yee Tey1, Almut Dufner2, Klaus-Peter Knobeloch2
1Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown St., Liverpool, L69 3BX, UK.
Abstract:
The immune checkpoint regulator CTLA4 is an unusually short-lived membrane protein. Here we show that its lysosomal degradation is dependent on ubiquitylation at Lysine residues 203 and 213. Inhibition of the v-ATPase partially restores CTLA4 levels following cycloheximide treatment, but also reveals a fraction that is secreted in exosomes. The endosomal deubiquitylase, USP8, interacts with CTLA4 and its loss enhances CTLA4 ubiquitylation in cancer cells, mouse CD4+ T cells and in cancer cell-derived exosomes. Depletion of the USP8 adapter protein, HD-PTP, but not ESCRT-0 recapitulates this cellular phenotype, but shows distinct properties vis-à-vis exosome incorporation. Re-expression of wild-type USP8, but neither a catalytically inactive, nor a localization-compromised ΔMIT domain mutant can rescue delayed degradation of CTLA4, or counteract its accumulation in clustered endosomes. UbiCRest analysis of CTLA4-associated ubiquitin chain linkages identifies a complex mixture of conventional Lys63- and more unusual Lys27- and Lys29-linked polyubiquitin chains that may underly the rapidity of protein turnover.
Insights
The immune checkpoint protein CTLA4
Area of Science:
- Immunology
- Cell Biology
- Protein Degradation
Background:
- Cytotoxic T-lymphocyte-associated protein 4 (CTLA4) is a crucial immune checkpoint regulator.
- CTLA4 is known for its unusually short lifespan as a membrane protein, suggesting rapid turnover mechanisms.
- Understanding CTLA4's degradation pathway is vital for modulating T-cell responses in cancer and autoimmunity.
Approach:
- Investigated the ubiquitylation sites and degradation pathway of CTLA4 using cycloheximide treatment and v-ATPase inhibition.
- Utilized co-immunoprecipitation and UbiCRest analysis to identify interacting proteins and ubiquitin chain linkages.
- Examined the role of the deubiquitylase USP8 and its adapter protein HD-PTP in CTLA4 trafficking and degradation.
Key Points:
- CTLA4 degradation is dependent on ubiquitylation at Lysine 203 and 213.
- USP8 deubiquitylase and its adapter HD-PTP promote CTLA4 turnover.
- CTLA4 is also secreted via exosomes, a process influenced by USP8 and HD-PTP.
- Specific ubiquitin chain linkages (Lys63, Lys27, Lys29) on CTLA4 contribute to its rapid degradation.
Conclusions:
- The study elucidates a novel ubiquitylation-dependent lysosomal degradation pathway for CTLA4 involving USP8.
- Identified distinct roles for USP8 and HD-PTP in CTLA4 degradation and exosome secretion.
- The findings provide new insights into the regulation of CTLA4 stability and function, with implications for immunotherapy.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Anaphase Promoting Complex
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

